← Product Code [DQY](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQY) · K092174

# ENABLER-P CATHETER SYSTEM, MODEL 3000 (K092174)

_Endocross, Ltd. · DQY · Dec 30, 2009 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQY/K092174

## Device Facts

- **Applicant:** Endocross, Ltd.
- **Product Code:** [DQY](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQY.md)
- **Decision Date:** Dec 30, 2009
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.1250
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

## Indications for Use

The ENABLER-P Catheter System is intended to be used in conjunction with a steerable guidewire to access discrete regions of the peripheral vasculature and for guidewire exchange.

## Device Story

The ENABLER-P Catheter System is a dual-lumen intravascular catheter used to access remote peripheral vasculature. It operates in conjunction with a 0.035" steerable guidewire. The system includes an optional Pressure Control Unit (PCU) to automate the inflation and deflation of a distal balloon on the catheter, which provides distal anchoring and support for guidewire advancement. The device is used by clinicians in a sterile environment. The PCU is supplied non-sterile with a sterile cover. The system facilitates guidewire exchange and navigation within the cardiovascular system. Benefits include improved access to remote vascular regions and enhanced support during guidewire procedures.

## Clinical Evidence

No clinical data provided. Evidence consists of biocompatibility testing, in vitro bench studies, and in vivo studies demonstrating that the device satisfies functional performance requirements.

## Technological Characteristics

Dual-lumen intravascular catheter; distal balloon for anchoring; optional automated Pressure Control Unit (PCU) for balloon inflation/deflation. Packaged in Tyvek/Poly pouch; sterilized via ethylene oxide gas. Single-use only. Non-pyrogenic.

## Regulatory Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

## Predicate Devices

- ENABLER-P Catheter ([K082339](/device/K082339.md), [K083833](/device/K083833.md))
- Metricath System ([K024000](/device/K024000.md))
- Everest 20cc Inflation Device ([K942269](/device/K942269.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

EndoCross ENABLER-P Catheter System 510(k)

## 510(k) SUMMARY

### EndoCross's ENABLER-P Catheter System

# Applicant's Information

| Date Prepared:    | July 17, 2009                                                                        |
|-------------------|--------------------------------------------------------------------------------------|
|                   | DEC 30 2009                                                                          |
| Name and Address: | EndoCross Ltd<br>New Industrial Park, Building 7<br>P.O.B 620, Yoqneam 20692, Israel |
| Contact Person:   | Yaron Eshel                                                                          |
|                   | Tel: +972-4-9090030                                                                  |
|                   | Fax: +972-4-9090055                                                                  |

#### Device Information

| Classification:      | DQY                                          |
|----------------------|----------------------------------------------|
| Trade Name:          | ENABLER-P Catheter System                    |
| Common Name:         | Percutaneous Catheter System                 |
| Classification Name: | Percutaneous Catheter, DQY / 21 CFR 870.1250 |

# Predicate Devices

- ENABLER-P Catheter manufactured by Endocross (K082339, K083833) .
- Metricath System manufactured by Angiometrx Inc (K024000) .
- Everest 20cc Inflation Device manufactured by Medtronic (K942269)

#### Intended Use / Indications for Use

The ENABLER-P Catheter System is intended to be used in conjunction with a steerable guidewire to access discrete regions of the peripheral vasculature and for guidewire exchange.

{1}------------------------------------------------

### Technological Characteristics

The ENABLER-P Catheter System is comprised of the ENABLER-P Catheter, the ENABLER Pressure Control Unit (PCU), and accessories including a sterile cover, syringe, manifold and extension tube.

The ENABLER-P Catheter is a dual-lumen intravascular catheter intended for percutaneous use. It is designed for use in conjunction with a 0.035" guidewire to gain access to locations within the cardiovascular system that are remote from the site of insertion. Once accessed, guidewires may be exchanged within the catheter. In addition, the ENABLER-P Catheter, using a distal balloon, can provide distal anchoring and support the advancement of the guidewire.

The ENABLER-P Catheter is packaged in a Tyvek/Poly pouch to form a sterile barrier. The packaged catheter is sterilized by ethylene oxide gas. The ENABLER-P Catheter is provided "STERILE" and "Non-pyrogenic", and is intended for single use only.

The ENABLER Pressure Control Unit (PCU) an optional accessory used to automate the inflation and deflation of the catheter's balloon. The PCU is single use and supplied non sterile with a specially designed sterile cover to allow proper use in sterile areas.

#### Biocompatibility And Performance Data

Biocompatibility testing, in vitro bench studies, and in vivo studies were conducted to evaluate the biological and performance characteristics of the ENABLER-P Catheter. Biocompatibility test results indicate that the device is biocompatible. Performance test results indicate that the device satisfies functional performance requirements when used as indicated.

#### Substantial Equivalence

. İ

The ENABLER-P Catheter System is substantially equivalent to the cleared ENABLER-P Catheter manufactured by EndoCross, the Medtronic Everest 20cc Inflation Device and the Angiometrx Metricath System.

The ENABLER-P Catheter System has the same intended use as the cleared ENABLER-P Catheter and similar technological characteristics as the cleared ENABLER-P Catheter, the Medtronic Everest 20cc Inflation Device and the Angiometrx Inc., Metricath System. Any differences in technological characteristics or principles do not raise new questions of safety or efficacy.

Thus, the ENABLER-P Catheter System is substantially equivalent.

{2}------------------------------------------------

#### DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle, there is an abstract symbol resembling an eagle or bird in flight, rendered in a stylized, minimalist design.

#### Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002

EndoCross, Ltd. c/o John J. Smith, M.D., J.D. Hogan & Hartson LLP Columbia Square 555 Thirteenth Street N.W. Washington, D.C. 20004

DEC 3 0 2009

Re: K092174

Trade/Device Name: ENABLER-P Catheter System Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II (two) Product Code: DQY Dated: December 22, 2009 Received: December 22, 2009

#### Dear Dr. Smith:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{3}------------------------------------------------

Page 2 - John J. Smith, M.D., J.D.

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

#### Indications for Use Statement

| 510(k) Number (if known): | K092174 |
|---------------------------|---------|
|---------------------------|---------|

Device Name: ENABLER-P Catheter System

Intended Use / Indications for Use:

The ENABLER-P Catheter System is intended to be used in conjunction with a steerable guidewire to access discrete regions of the peripheral vasculature and for guidewire exchange.

Prescription Use ﮨﮯ۔ (Part 21 C.F.R. 801 Subpart D) AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 

of

(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K92174 92074

13

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQY/K092174](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQY/K092174)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com